Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Caterina Turco

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal of Cellular Biochemistry|November 6, 2021
BAG3 induces α-SMA expression in human fibroblasts and its over-expression correlates with poorer survival in fibrotic cancer patientsMargot De Marco, Nicoletta Del Papa, Francesca Reppucci, et al.
The International Journal of Biochemistry & Cell Biology|May 12, 2007
Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 proteinAlessandra Rosati, Massimo Ammirante, Antonio Gentilella, et al.
British Journal of Cancer|June 8, 2021
An emerging role for BAG3 in gynaecological malignanciesMargot De Marco, Antonia Falco, Roberta Iaccarino, et al.
Journal of Medicinal Chemistry|February 2, 2011
Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivoAnna Basile, Annarita Del Gatto, Donatella Diana, et al.
Cancer Research|February 3, 2006
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient miceCarmelo Carlo-Stella, Massimo Di Nicola, Maria Caterina Turco, et al.
The Journal of Clinical Endocrinology and Metabolism|November 11, 2011
BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF proteinGennaro Chiappetta, Anna Basile, Claudio Arra, et al.
Oncotarget|March 1, 2018
Identification of BAG3 target proteins in anaplastic thyroid cancer cells by proteomic analysisFrancesca Galdiero, Anna Maria Bello, Anna Spina, et al.
Molecular Oncology|April 12, 2019
Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancerAnna Basile, Margot De Marco, Michelina Festa, et al.
Gut|August 13, 2017
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8<sup>+</sup> T cell number and tumour growth in pancreatic cancerVittoria Iorio, Alessandra Rosati, Raffaella D'Auria, et al.
Seminars in Cell & Developmental Biology|September 3, 2017
Role of BAG3 in cancer progression: A therapeutic opportunityMargot De Marco, Anna Basile, Vittoria Iorio, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Cellular Biochemistry|November 6, 2021
BAG3 induces α-SMA expression in human fibroblasts and its over-expression correlates with poorer survival in fibrotic cancer patientsMargot De Marco, Nicoletta Del Papa, Francesca Reppucci, et al.
The International Journal of Biochemistry & Cell Biology|May 12, 2007
Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 proteinAlessandra Rosati, Massimo Ammirante, Antonio Gentilella, et al.
British Journal of Cancer|June 8, 2021
An emerging role for BAG3 in gynaecological malignanciesMargot De Marco, Antonia Falco, Roberta Iaccarino, et al.
Journal of Medicinal Chemistry|February 2, 2011
Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivoAnna Basile, Annarita Del Gatto, Donatella Diana, et al.
Cancer Research|February 3, 2006
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient miceCarmelo Carlo-Stella, Massimo Di Nicola, Maria Caterina Turco, et al.
The Journal of Clinical Endocrinology and Metabolism|November 11, 2011
BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF proteinGennaro Chiappetta, Anna Basile, Claudio Arra, et al.
Oncotarget|March 1, 2018
Identification of BAG3 target proteins in anaplastic thyroid cancer cells by proteomic analysisFrancesca Galdiero, Anna Maria Bello, Anna Spina, et al.
Molecular Oncology|April 12, 2019
Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancerAnna Basile, Margot De Marco, Michelina Festa, et al.
Gut|August 13, 2017
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8<sup>+</sup> T cell number and tumour growth in pancreatic cancerVittoria Iorio, Alessandra Rosati, Raffaella D'Auria, et al.
Seminars in Cell & Developmental Biology|September 3, 2017
Role of BAG3 in cancer progression: A therapeutic opportunityMargot De Marco, Anna Basile, Vittoria Iorio, et al.
Pageof 7